Evaluation of Performance and Safety of Colonic Irrigation With the Colon Hydromat as a Non-oral Bowel Preparation for Colonoscopy
Prospective, Single-center, Single-arm, Open-label Observational PMCF Study - Evaluation of Performance and Safety of Colonic Irrigation With the Colon Hydromat as a Non-oral Bowel Preparation for Colonoscopy
1 other identifier
observational
28
1 country
1
Brief Summary
This is a clinical study with a medical device that bears the CE mark (approval for marketing in the EU) and is applied within its intended use. It is a prospective, single-centre, single-arm, open-label, observational post-market clinical follow-up (PMCF) study using the "Colon Hydromat" system for bowel preparation prior to colonoscopy. The patients will be treated according to the clinical routine and in accordance with the current IFU. Aim of the study is to confirm safety and performance (effectiveness) of colon hydrotherapy as bowel preparation for colonoscopy. Colonic irrigation is regarded as a substitute for standard oral colonic purgative solutions for colonoscopy preparation, especially for patients, who cannot tolerate oral preparations or want to have alternatives because they have experienced the current oral preparations as a burdensome process.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Feb 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 16, 2020
CompletedFirst Posted
Study publicly available on registry
December 24, 2020
CompletedStudy Start
First participant enrolled
February 3, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 15, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2021
CompletedFebruary 8, 2021
December 1, 2020
1 month
December 16, 2020
February 3, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Quality of bowel preparation (Colonic Cleanliness), evaluated through the Boston Bowel Preparation Scale (BBPS).
Quality of bowel preparation validated by numerical scale for bowel cleanse (0-9 best)
day 1
Adverse device events (ADE) and collection of SADE (device or procedure related).
Assessment of ADE: Patients will be asked in questionnaires, if they had any adverse events, especially nausea, vomiting, pain/cramps, dizziness and headache and rate of patients where colonic irrigation had to be aborted. Assessment of SADE: will be assessed at end of colonoscopy by investigator.
day 1
Secondary Outcomes (12)
BBPS for each segment.
day 1
Patient satisfaction.
day 1
User satisfaction and usability.
day 1
Details to colonic irrigation.
day 1
Details to colonic irrigation.
day 1
- +7 more secondary outcomes
Study Arms (1)
Single Group Assignment
Patients will receive colonic irrigation as bowel preparation prior to colonoscopy.
Interventions
A designated health professional will administer to the patient the colonic irrigation procedure - using the "Colon Hydromat" device, a CE certified device for colonic irrigation and cleansing before endoscopic procedures.
Eligibility Criteria
All patients (men and women) who are planned for a colonoscopy and where anorectal colonic irrigation with the specula can be performed, will be included into the study. The colonic irrigation is regarded as alternative bowel preparation to oral preparations, especially for patients who: * cannot tolerate oral preparations (e.g. cannot drink large volumes, nausea, vomiting), or * want to have alternatives because they have experienced the current oral preparations as a burdensome process, or * had an inadequate colon cleansing following traditional oral preparation, in order to complete the colonoscopy at the same day.
You may qualify if:
- desire an alternative bowel preparation method to standard of oral polyethylene glycol or other orally taken purgatives, or do not tolerate the oral preparations, or had an inadequate colon cleansing following traditional oral preparation, in order to complete the colonoscopy at the same day.
- Adult patients (≥ 18 years old) having signed the informed consent.
- Being able to respond to the self-administered questionnaire.
You may not qualify if:
- Psychiatric conditions and inability to provide informed consent
- Emergency colonoscopy
- Off-label use (application is not within the IFU)
- Pregnancy and lactation period
- The patient has one of the contraindications listed in the IFU.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Herrmann Apparatebau GmbHlead
- CERES GmbHcollaborator
Study Sites (1)
Internistische Gemeinschaftspraxis für Verdauungs- und Stoffwechselerkrankungen
Leipzig, 04105, Germany
Study Officials
- PRINCIPAL INVESTIGATOR
Niels Teich, Prof. Dr. med.
Study centre Leipzig - Internistic Joint Practice
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 16, 2020
First Posted
December 24, 2020
Study Start
February 3, 2021
Primary Completion
March 15, 2021
Study Completion
March 30, 2021
Last Updated
February 8, 2021
Record last verified: 2020-12